SYRS   $0.116  -8.30% Market Open

Syros Pharmaceuticals, Inc.
Total Cash 58.27M
totalCashPerShare 2.172
EBITDA -110.18M
Total Debt 60.23M
quickRatio 2.053
currentRatio 2.252
Total Revenue 386.00K
debtToEquity
Revenue/Share 0.01
ROA -0.59883
ROE -7.76957
grossProfits
freeCashflow -57.94M
operatingCashflow -100.02M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -288.9171
profitMargins 0.0
enterpriseValue 69.84M
forwardPE -0.92105263
floatShares 13.86M
sharesOutstanding 26.83M
sharesShort 952.60K
sharesShortPriorMonth 1.10M
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.81%
Short Ratio help_outline 4.74%
shortPercentOfFloat 0.04%
impliedSharesOutstanding
bookValue -0.415
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -97.81M
trailingEps -3.07%
forwardEps -2.66%
enterpriseToEbitda -0.63
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.7 4Q 2024
institutionsCount 88
lastUpdated Nov. 7, 2024, 2:29 a.m.